Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Capital Employed (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Return on Capital Employed for 15 consecutive years, with 0.98% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 19.0% to 0.98% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.98%, a 19.0% decrease, with the full-year FY2024 number at 0.69%, down 30.0% from a year prior.
  • Return on Capital Employed was 0.98% for Q3 2025 at Creative Medical Technology Holdings, down from 0.79% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 2.15% in Q2 2021 to a low of 0.98% in Q3 2025.
  • A 5-year average of 0.34% and a median of 0.59% in 2022 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 187bps in 2021, then crashed -247bps in 2022.
  • Creative Medical Technology Holdings' Return on Capital Employed stood at 0.51% in 2021, then decreased by -15bps to 0.59% in 2022, then rose by 15bps to 0.5% in 2023, then plummeted by -78bps to 0.89% in 2024, then dropped by -10bps to 0.98% in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Return on Capital Employed are 0.98% (Q3 2025), 0.79% (Q2 2025), and 0.87% (Q1 2025).